{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:20:39Z","timestamp":1783948839444,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.109956","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T11:07:45Z","timestamp":1591441665000},"page":"109956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Enkephalins as a therapeutic intervention for visceral leishmaniasis"],"prefix":"10.1016","volume":"144","author":[{"given":"Ganesh","family":"Yadagiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Lal","family":"Mudavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109956_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.mehy.2020.109956_b0010","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.15-0408","article-title":"Social and economic burden of human leishmaniasis","volume":"94","author":"Okwor","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mehy.2020.109956_b0015","unstructured":"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis. Leishmaniasis. 2020."},{"key":"10.1016\/j.mehy.2020.109956_b0020","doi-asserted-by":"crossref","unstructured":"Yadagiri G, Singh PP. Chemotherapy and experimental models of visceral leishmaniasis. Infect. Dis. Your Heal. 2018: 63\u201397.","DOI":"10.1007\/978-981-13-1577-0_5"},{"key":"10.1016\/j.mehy.2020.109956_b0025","first-page":"108","article-title":"Post-kala-azar dermal leishmaniasis","volume":"18","author":"Zijlstra","year":"2003","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mehy.2020.109956_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40249-016-0112-2","article-title":"Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective","volume":"5","author":"Singh","year":"2016","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.mehy.2020.109956_b0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis \u2013 current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mehy.2020.109956_b0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.62883","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"Moore","year":"2010","journal-title":"J Glob Infect Dis"},{"key":"10.1016\/j.mehy.2020.109956_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/oxfordjournals.bmb.a071784","article-title":"Central distribution of opioid peptides","volume":"39","author":"Cuello","year":"1983","journal-title":"Br Med Bull"},{"key":"10.1016\/j.mehy.2020.109956_b0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1476-5381.1977.tb07557.x","article-title":"The distribution of methionine-enkephalin and Leucine-enkephalin in the brain and peripheral tissues","volume":"61","author":"Hughes","year":"1977","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2020.109956_b0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-0102(95)00933-K","article-title":"Molecular biology of the opioid receptors: structures, functions and distributions","volume":"23","author":"Minami","year":"1995","journal-title":"Neurosci Res"},{"key":"10.1016\/j.mehy.2020.109956_b0060","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/clin.1996.4287","article-title":"Methionine enkephalin: a new cytokine \u2013 human studies","volume":"82","author":"Plotnikoff","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.mehy.2020.109956_b0065","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/bmb\/ldl003","article-title":"Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment","volume":"75\u201376","author":"Roberts","year":"2005","journal-title":"Br Med Bull"},{"key":"10.1016\/j.mehy.2020.109956_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2013.00156","article-title":"Interferon gamma in leishmaniasis","volume":"4","author":"Kima","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2020.109956_b0075","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1002\/1521-4141(200009)30:9<2555::AID-IMMU2555>3.0.CO;2-X","article-title":"Peroxovanadium-mediated protection against murine leishmaniasis: role of the modulation of nitric oxide","volume":"30","author":"Matte","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.mehy.2020.109956_b0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000091127","article-title":"In vitro modulation of cytokine expression by enkephalin-derived peptides","volume":"12","author":"Piva","year":"2006","journal-title":"NeuroImmunoModulation"},{"key":"10.1016\/j.mehy.2020.109956_b0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/clin.1996.4287","article-title":"Methionine enkephalin: a new cytokine \u2014 human studies","volume":"82","author":"Plotnikoff","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.mehy.2020.109956_b0090","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1987.tb35753.x","article-title":"Immunologic properties of therapeutic implications in AIDS, ARC, and Cancer","volume":"496","author":"Wybran","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2020.109956_b0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0162-3109(94)90020-5","article-title":"Lymphokines production by concanavalin A-stimulated mouse splenocytes: modulation by Met-enkephalin and a related peptide","volume":"27","author":"Singh","year":"1994","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.mehy.2020.109956_b0100","article-title":"Enkephalins-modulation of Plasmodium cynomolgi antigens-induced colony-stimulating factors elaboration by macrophages","author":"Singh","year":"1991","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.mehy.2020.109956_b0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0143-4179(98)90017-8","article-title":"The role of cyto kines in MET-enkephalin \u2013 modulated nitric oxide release","volume":"32","author":"Marottp","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mehy.2020.109956_b0110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/nbt0788-810","article-title":"Immunomodulatory components present in IMREG-1, an experimental immunosupportive biologic","volume":"6","author":"Sinha","year":"1988","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mehy.2020.109956_b0115","first-page":"98","article-title":"Development of immunomodulators for treatment of HIV infection","volume":"23","author":"Gottlieb","year":"1990","journal-title":"Lymphology"},{"key":"10.1016\/j.mehy.2020.109956_b0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0192-0561(96)00033-1","article-title":"Anti-retroviral activity of methionine enkephalin and AZT in a murine cell culture","volume":"18","author":"Sin","year":"1996","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.mehy.2020.109956_b0125","doi-asserted-by":"crossref","unstructured":"Kaur A, Kinhikar AG, Singh PP. Bioimmunotherapy of rodent malaria: Co-treatment with recombinant mouse granulocyte-macrophage colony-stimulating factor and an enkephalin fragment peptide Tyr-Gly-Gly. Acta Trop 2004;91:27\u201341. doi:10.1016\/j.actatropica.2004.02.009.","DOI":"10.1016\/j.actatropica.2004.02.009"},{"key":"10.1016\/j.mehy.2020.109956_b0130","first-page":"528","article-title":"Protection of mice from malaria after co-administration of recombinant mouse granulocyte-macrophage colony-stimulating factor and methionine-enkephalin","volume":"12","author":"Singh","year":"2001","journal-title":"Eur Cytokine Netw"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720306526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720306526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:02Z","timestamp":1759692122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720306526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":26,"alternative-id":["S0306987720306526"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109956","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enkephalins as a therapeutic intervention for visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109956"}}